Author

Maryam Clausen

AstraZeneca (Sweden)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adil MardinoğluiD· 2 shared Jan BoréniD· 2 shared Johannes Wikström· 2 shared Malin C. LeviniD· 2 shared Mohammad Bohlooly‐YiD· 2 shared Muhammad ArifiD· 2 shared Abdel Wahad Bidar· 1 shared Amir Taheri‐GhahfarokhiiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Adil MardinoğluORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integrative Analysis of Left Ventricle and Epicardial Adipose Tissue Identifies SDHA and OGDH as Candidate Targets for Ischemic Heart Disease

Muhammad Arif, Stephen Doran, Maryam Clausen, Johannes Wikström, Mohammad Bohlooly‐Y, Elias Björnson, Liam Davidsson, Anders Jeppsson, Malin C. Levin, Adil Mardinoğlu, Jan Borén

iScience · Jun 12, 2026Peer-reviewedSystems Biology

Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction

Muhammad Arif, Martina Klevstig, Rui Benfeitas, Stephen F. Doran, Hasan Türkez, Mathias Uhlén, Maryam Clausen, Johannes Wikström, Damla Etal, Cheng Zhang, Malin C. Levin, Adil Mardinoğlu, Jan Borén

The paper analyzes transcriptomic changes in heart and other metabolically active tissues after myocardial infarction in mice, identifying common and tissue-specific biological responses.

eLife · May 10, 2021Peer-reviewedSystems Biology

ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatment

Anders Lundin, Michelle J. Porritt, Himjyot Jaiswal, Frank Seeliger, Camilla Johansson, Abdel Wahad Bidar, Lukas Badertscher, Emma Jane Davies, Elizabeth L. Hardaker, Carla P. Martins, Therése Admyre, Amir Taheri‐Ghahfarokhi, Jenna Bradley, Anna Schantz, Babak Alaei-Mahabadi, , Marcello Maresca

This paper introduces an inducible CRISPR-Cas9 system for preclinical drug discovery, enabling controlled genome editing in mice to model cancer and test therapies.

bioRxiv · Apr 6, 2020 · PreprintGenomics